Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

BUY
$155.97 - $200.09 $77,985 - $100,045
500 New
500 $89,000
Q2 2021

Aug 11, 2021

SELL
$155.9 - $187.99 $2.09 Million - $2.52 Million
-13,411 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$144.0 - $169.39 $692,784 - $814,935
-4,811 Reduced 26.4%
13,411 $2.11 Million
Q4 2020

Feb 10, 2021

SELL
$157.07 - $174.35 $73,194 - $81,247
-466 Reduced 2.49%
18,222 $3.02 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $37,154 - $44,815
-271 Reduced 1.43%
18,688 $3.09 Million
Q2 2020

Aug 10, 2020

BUY
$111.92 - $142.53 $660,999 - $841,782
5,906 Added 45.25%
18,959 $2.6 Million
Q1 2020

Apr 20, 2020

SELL
$92.66 - $144.94 $251,293 - $393,077
-2,712 Reduced 17.2%
13,053 $1.54 Million
Q4 2019

Jan 31, 2020

BUY
$116.25 - $133.25 $16,042 - $18,388
138 Added 0.88%
15,765 $2.09 Million
Q3 2019

Oct 31, 2019

BUY
$112.57 - $128.43 $43,452 - $49,573
386 Added 2.53%
15,627 $1.95 Million
Q2 2019

Aug 07, 2019

BUY
$97.98 - $114.28 $9,700 - $11,313
99 Added 0.65%
15,241 $1.73 Million
Q1 2019

Apr 25, 2019

BUY
$81.56 - $100.67 $33,765 - $41,677
414 Added 2.81%
15,142 $1.52 Million
Q4 2018

Feb 01, 2019

SELL
$79.28 - $95.27 $15,221 - $18,291
-192 Reduced 1.29%
14,728 $1.26 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $102,120 - $114,020
-1,223 Reduced 7.58%
14,920 $1.37 Million
Q2 2018

Jul 20, 2018

SELL
$79.9 - $89.2 $6,312 - $7,046
-79 Reduced 0.49%
16,143 $1.38 Million
Q1 2018

May 08, 2018

SELL
$71.51 - $84.69 $63,000 - $74,611
-881 Reduced 5.15%
16,222 $1.36 Million
Q4 2017

Feb 07, 2018

BUY
$63.24 - $72.8 $32,378 - $37,273
512 Added 3.09%
17,103 $1.23 Million
Q3 2017

Oct 19, 2017

BUY
$59.73 - $65.4 $990,980 - $1.09 Million
16,591
16,591 $1.06 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Ls Investment Advisors, LLC Portfolio

Follow Ls Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.